LACEY LUNDGREN: Open Payments
NPI 1689088205 · BASTROP, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 13 payments from 7 companies in 2025. Trend: 2023 $125 · 2024 $0 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Corium, LLC | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: SPRAVATO, REXULTI, Azstarys, FANAPT, Auvelity, Qelbree, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
